| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $474,299 ) |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HL131652 | Defining the Mechanisms of Lymphatic Vascular Growth and Function | 000 | 8 | NIH | 11/6/2024 | $474,299 |
| | 2025 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM149343 | Mechanisms of cohesin regulation in vertebrates | 000 | 2 | NIH | 11/5/2024 | $0 |
| | 2025 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 000 | 3 | NIH | 11/1/2024 | $0 |
| | 2025 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 000 | 3 | NIH | 11/1/2024 | $0 |
| | 2025 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 000 | 3 | NIH | 11/1/2024 | $0 |
| | 2025 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 000 | 3 | NIH | 11/1/2024 | $0 |
| | 2025 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 000 | 3 | NIH | 11/1/2024 | $0 |
| | 2025 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM126980 | Understanding Cell Division | 000 | 6 | NIH | 11/5/2024 | $0 |
| | 2025 | 2020 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AR072401 | Mechanisms of Lupus Disease Transition and Hydroxychloroquine Immune Modulation | 000 | 4 | NIH | 10/16/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $39,320,289 ) (Continued on the next page) |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | U01AI176244 | Autoimmune Drivers and Protectors Team Science (ADAPTS) | 001 | 2 | NIH | 5/23/2024 | $128,808 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM152165 | Centromere behaviors that promote proper chromosome segregation in meiosis and mitosis | 001 | 1 | NIH | 5/13/2024 | $13,945 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM152165 | Centromere behaviors that promote proper chromosome segregation in meiosis and mitosis | 000 | 1 | NIH | 12/14/2023 | $426,250 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AR073855 | Discovery and Characterization of Genetic Risk Loci in Sjogren's Syndrome | 000 | 5 | NIH | 8/19/2024 | $721,627 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AI178947 | γδTCR-dependent and independent differentiation of innate lymphoid cells | 000 | 2 | NIH | 6/14/2024 | $682,186 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG074551 | Dissecting the integrated mechanisms of protein turnover to prevent proteostatic decline with aging | 000 | 3 | NIH | 6/4/2024 | $649,901 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM126980 | Understanding Cell Division | 000 | 6 | NIH | 6/27/2024 | $460,350 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R03AI175661 | Establishing a lineage tracing system for studying thymus-derived innate lymphoid cells | 001 | 2 | NIH | 5/10/2024 | $8,525 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG070035 | Role of estrogen receptor-a in aging and sex-specific responses to 17a-estradiol | 000 | 4 | NIH | 6/14/2024 | $514,469 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R03AI175661 | Establishing a lineage tracing system for studying thymus-derived innate lymphoid cells | 000 | 2 | NIH | 2/20/2024 | $76,725 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | P20GM139763 | Center for Cellular Metabolism Research in Oklahoma | 002 | 4 | NIH | 9/17/2024 | $997,408 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AR080896 | PDGFRB Signaling in Progressive Skin Disease | 000 | 2 | NIH | 1/25/2024 | $476,629 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | P20GM139763 | Center for Cellular Metabolism Research in Oklahoma | 000 | 4 | NIH | 1/30/2024 | $2,359,801 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AR080896 | PDGFRB Signaling in Progressive Skin Disease | 001 | 2 | NIH | 5/29/2024 | $37,071 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | P20GM139763 | Center for Cellular Metabolism Research in Oklahoma | 001 | 4 | NIH | 5/3/2024 | $262,199 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R21AG085486 | The role of tetraspanin-regulated endolysosomal trafficking in Alzheimer's Disease | 000 | 1 | NIH | 8/26/2024 | $252,750 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | DP5OD033443 | Sex chromosomal regulation of hippocampal microglial activation with Alzheimer's disease and aging | 000 | 3 | NIH | 8/29/2024 | $1 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | DP5OD033443 | Sex chromosomal regulation of hippocampal microglial activation with Alzheimer's disease and aging | 000 | 3 | NIH | 8/29/2024 | $436,999 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | P30GM149376 | Expanding Excellence in Developmental Biology in Oklahoma | 001 | 2 | NIH | 8/29/2024 | $1,050,754 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HL131652 | Defining the Mechanisms of Lymphatic Vascular Growth and Function | 001 | 7 | NIH | 6/13/2024 | $43,212 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01DE032911 | Aging and Oxidative Stress Influence Salivary Gland Disease in Sjogren's Syndrome | 001 | 2 | NIH | 6/13/2024 | $40,895 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG064951 | Does insulin sensitivity impact the potential of metformin to slow aging? | 001 | 5 | NIH | 6/28/2024 | $56,572 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HL160955 | Increasing glycolysis in the diabetic heart is cardioprotective and improves glucose tolerance | 000 | 3 | NIH | 8/22/2024 | $437,000 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM149343 | Mechanisms of cohesin regulation in vertebrates | 002 | 2 | NIH | 6/21/2024 | $42,625 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 008 | 3 | NIH | 7/11/2024 | $0 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 008 | 3 | NIH | 7/11/2024 | $0 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 008 | 3 | NIH | 7/11/2024 | $0 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 008 | 3 | NIH | 7/11/2024 | $0 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 008 | 3 | NIH | 7/11/2024 | $0 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 009 | 3 | NIH | 8/15/2024 | $0 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 009 | 3 | NIH | 8/15/2024 | $0 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 009 | 3 | NIH | 8/15/2024 | $0 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 009 | 3 | NIH | 8/15/2024 | $0 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 009 | 3 | NIH | 8/15/2024 | $0 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 003 | 3 | NIH | 3/25/2024 | $550,000 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 003 | 3 | NIH | 3/25/2024 | $100,000 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 003 | 3 | NIH | 3/25/2024 | $1,050,000 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 003 | 3 | NIH | 3/25/2024 | $1,000,000 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 003 | 3 | NIH | 3/25/2024 | $1,000,000 |
|
